What is the official website of MSD Türkiye ?

The official website of MSD Türkiye is http://www.msd.com.tr.

What is MSD Türkiye's cybersecurity risk score?

MSD Türkiye has an AI-generated cybersecurity risk score of 755 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has MSD Türkiye experienced?

According to Rankiteo, MSD Türkiye currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has MSD Türkiye been affected by any supply chain cyber incidents ?

According to Rankiteo, MSD Türkiye has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does MSD Türkiye have SOC 2 Type 1 certification ?

According to Rankiteo, MSD Türkiye is not certified under SOC 2 Type 1.

Does MSD Türkiye have SOC 2 Type 2 certification ?

According to Rankiteo, MSD Türkiye does not hold a SOC 2 Type 2 certification.

Does MSD Türkiye comply with GDPR ?

According to Rankiteo, MSD Türkiye is not listed as GDPR compliant.

Does MSD Türkiye have PCI DSS certification ?

According to Rankiteo, MSD Türkiye does not currently maintain PCI DSS compliance.

Does MSD Türkiye comply with HIPAA ?

According to Rankiteo, MSD Türkiye is not compliant with HIPAA regulations.

Does MSD Türkiye have ISO 27001 certification ?

According to Rankiteo,MSD Türkiye is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does MSD Türkiye operate in ?

MSD Türkiye operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does MSD Türkiye have ?

MSD Türkiye employs approximately 325 people worldwide.

Does MSD Türkiye own any subsidiaries ?

MSD Türkiye presently has no subsidiaries across any sectors.

How many LinkedIn followers does MSD Türkiye have ?

MSD Türkiye's official LinkedIn profile has approximately 33,342 followers.

Does MSD Türkiye have a Crunchbase profile ?

No, MSD Türkiye does not have a profile on Crunchbase.

Does MSD Türkiye have a LinkedIn profile ?

Yes, MSD Türkiye maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/msdturkey.

How many cybersecurity incidents has MSD Türkiye experienced ?

As of June 12, 2026, Rankiteo reports that MSD Türkiye has experienced 1 cybersecurity incidents.

How many peer or competitor companies does MSD Türkiye have ?

MSD Türkiye has an estimated 5,686 peer or competitor companies worldwide.

What types of cybersecurity incidents has MSD Türkiye faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

MSD Türkiye

Boost Score +25 with badge (5 left)

755

/1000

Fair

780

/1000

Fair

MSD Türkiye Vendor Cyber Rating & Cyber Score

msd.com.tr

Add Your Compliance Badge

Ürünlerimizle ilgili yan etki & kalite şikayetlerini lütfen sosyal medya hesaplarımıza değil, https://www.msd.com.tr/iletisim-formlari/'na bildirin. MSD olarak, 130 yılı aşkın süredir hayatları kurtarma ve iyileştirme misyonu ile dünyanın en zorlu hastalıkları için ilaçlar ve aşılar sunuyor, yaşam için keşfediyoruz. MSD, merkezi Kenilworth, N.J., ABD'de bulunan Merck & Co., Inc.'in ticari adıdır. MSD, sağlığa erişimi artırmaya yönelik kararlılığını, gelişmiş kural, program ve iş birlikleri uygulamaları ile ortaya koymaktadır. Günümüzde MSD, Dünyada ilk sırada yer alan Ar-Ge odaklı biyofarmasötik şirket olmayı amaçlayarak Kanser, Enfeksiyon Hastalıkları, HIV gibi hastalıklar, aşılar ve hayvan sağlığı çalışmalarını içeren, insanların ve

MSD Türkiye A.I CyberSecurity Scoring

Scoring History

MSD Türkiye

MSD Türkiye CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

MSD Türkiye

Breach

9/2025

MSD060270611182...

Loading…

A.I.

MSD Türkiye Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MSD Türkiye

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Türkiye in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for MSD Türkiye in 2026.

Incident Types MSD Türkiye vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Türkiye in 2026.

Incident History - MSD Türkiye (X = Date, Y = Severity)

Loading…

SUBSIDIARY

MSD Türkiye Subsidiaries

MSD Türkiye

Pharmaceutical Manufacturing

Website: http://www.msd.com.tr

Company Size: 325

MSDPharmaceutical Manufacturing

MSD EspañaPharmaceutical Manufacturing

MSD EgyptPharmaceutical Manufacturing

MSD Saúde AnimalVeterinary Services

MSD NetherlandsPharmaceutical Manufacturing

MSD Animal HealthPharmaceutical Manufacturing

MSD DeutschlandPharmaceutical Manufacturing

MSD FrancePharmaceutical Manufacturing

MSD LATAMPharmaceutical Manufacturing

MSD GCCPharmaceutical Manufacturing

MSD ItaliaPharmaceutical Manufacturing

MSD PortugalPharmaceutical Manufacturing

MSD GreecePharmaceutical Manufacturing

MSD Czech RepublicPharmaceutical Manufacturing

MSD in the UKPharmaceutical Manufacturing

MSD South AfricaPharmaceutical Manufacturing

MSD JordanPharmaceutical Manufacturing

MSD Animal Health Technology LabsTechnology, Information and Internet

MSD Animal Health UK LtdPharmaceutical Manufacturing

MSD LebanonPharmaceutical Manufacturing

MSD NorgePharmaceutical Manufacturing

MSD SlovenskoPharmaceutical Manufacturing

MSD BelgiumPharmaceutical Manufacturing

MSD SwitzerlandPharmaceutical Manufacturing

MSD SRBIJAPharmaceutical Manufacturing

MSD UkrainePharmaceutical Manufacturing

MSD RomaniaPharmaceutical Manufacturing

MSD ÖsterreichPharmaceutical Manufacturing

MSD MagyarországPharmaceutical Manufacturing

MSD PolskaPharmaceutical Manufacturing

MSD DanmarkPharmaceutical Manufacturing

MSD FinlandPharmaceutical Manufacturing

MSD SverigePharmaceutical Manufacturing

MSD Australia & New ZealandPharmaceutical Manufacturing

Loading…

MSD Türkiye Similar Companies

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Loading…

NEWS

MSD Türkiye CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-47238

SUMMARY

ClipBucket v5 is an open source video sharing platform. Prior to version 5.5.3 - #133, a normal authenticated user can edit another user's video subtitles because of a lack of authorization. They can upload subtitles, edit their name or delete them. This issue has been patched in version 5.5.3 - #133.

Published

Date2026-06-11

Updated

Date2026-06-11

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L

Impact Score

2.5

Exploitability

3.9

REFERENCES

https://github.com/MacWarrior/clipbucket-v5/security/advisories/GHSA-x468-whmw-c863

CVE-2026-45418

SUMMARY

ClipBucket v5 is an open source video sharing platform. Prior to version 5.5.3 - #132, any authenticated user who can upload videos can add multiple subtitles from different files and change their title (English, Spanish...). The POST /actions/subtitle_edit.php request used to change their title includes a number parameter which is vulnerable to SQL Injection. A boolean-based blind SQL injection can be used to exfiltrate sensitive data. This issue has been patched in version 5.5.3 - #132.

Published

Date2026-06-11

Updated

Date2026-06-11

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://github.com/MacWarrior/clipbucket-v5/security/advisories/GHSA-q233-m544-6jqr

CVE-2026-45060

SUMMARY

ClipBucket v5 is an open source video sharing platform. Prior to version 5.5.3 - #129, the actions/progress_video.php endpoint is vulnerable to blind SQL injection. Any unauthenticated user can exploit the ids parameter to execute SQL queries and exfiltrate sensitive data. This issue has been patched in version 5.5.3 - #129.

Published

Date2026-06-11

Updated

Date2026-06-11

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

3.9

REFERENCES

https://github.com/MacWarrior/clipbucket-v5/security/advisories/GHSA-wpq3-gxx7-c76h

CVE-2026-42846

SUMMARY

ClipBucket v5 is an open source video sharing platform. Prior to version 5.5.3 - #140, ClipBucket's Remote Play feature allows any authenticated user to add a video by importing an external URL as the source. Some shell commands are run with the URL as a parameter. The URL is concatenated directly into shell commands without escaping then executed, so any shell metacharacter in the URL is interpreted. This results in arbitrary command execution. This issue has been patched in version 5.5.3 - #140.

Published

Date2026-06-11

Updated

Date2026-06-11

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

3.9

REFERENCES

https://github.com/MacWarrior/clipbucket-v5/security/advisories/GHSA-hvfx-hxmr-28c7

CVE-2026-6250

SUMMARY

An authenticated format string vulnerability exists in the ONVIF service of Tapo C110 v2 due to improper handling of user-controlled input. Externally controlled data is interpreted as a format string, which can be used to manipulate stack memory, including control flow data such as return addresses. A remote authenticated attacker may redirect execution flow to existing internal functions, triggering an unauthorized factory reset, leading to loss of configuration, deletion of stored credentials and service disruption.

Published

Date2026-06-11

Updated

Date2026-06-11

RISK INFORMATION (Score: )

cvss4

Base Score: 7.0

Complexity: LOW

CVSS:4.0/AV:A/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…